Press release
E-prescribing Market: The Erx Solutions Segment Accounted Largest Share | While Erx Services Segment Is Expected to Register High Growth Rate
The report "E-prescribing Market by Product (Integrated Solutions, Standalone Solutions, Service (Support, Implementation, Training, Network)), Delivery Mode (Web, Cloud, On-premise), & End User (Hospital, Office-based Physicians, Pharmacy) - Global Forecast to 2021", The global e-prescribing market is expected to reach USD 1,403.2 Million by 2021 from USD 546.5 Million in 2016, at a CAGR of 20.8% during the forecast period.Browse 137 market data tables and 40 figures spread through 188 pages and in-depth TOC on "E-prescribing Market"
http://www.marketsandmarkets.com/Market-Reports/e-prescription-systems-market-910.html
Early buyers will receive 10% customization on this report.
Various government initiatives and incentive programs, rising focus on the reduction of fraud & abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail escalating healthcare costs are the major factors driving the growth of the global e-prescribing market.
On the basis of product, the e-prescribing services segment is expected to witness the highest growth during the forecast period.
Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=910
The high growth rate of the e-prescribing services segment can be attributed to the increasing adoption of e-prescribing that lead to a growing demand for training & education services; stringent regulations that have increased the application of implementation services for the validation & verification of hardware & software; and the need for frequent support and maintenance.
Based on delivery mode, the web & cloud-based segment is expected to dominate the market, with the highest growth rate during the forecast period. This growth of web & cloud-based segment can be primarily attributed to the improved performance and reliability by avoiding long deployment cycles, minimized upfront investments without incurring high infrastructure costs as the user can access the software from any compatible system using an access id or username and password, and that it does not require any complicated installation or implementation. The market is witnessing a shift from on-premise systems to web-hosted deployment of e-prescribing solutions.
Speak to Research Analyst:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=910
On the basis of end user, the hospitals segment is expected to grow at the highest rate during the forecast period. The major factors contributing to the high growth of this segment are the rising adoption rate of the e-prescribing solutions by hospitals in the U.S. and Europe, growing need to improve the profitability of healthcare operations, and growing focus to improve patient safety and advantages of e-prescribing over conventional handwritten prescribing systems.
The government initiatives to improve the quality of care delivered to patients and curtailing the soaring healthcare costs are also driving the adoption of e-prescribing solutions in hospitals.
Asia-Pacific possesses lucrative growth potential for the e-prescribing market during the forecast period. The high growth of this region can be attributed to healthcare organizations in the Asia-Pacific region that are actively moving towards digitization with a focus on streamlining their entire workflow and ensuring patient safety, a high share of the geriatric population resulting in significant growth in the prevalence of chronic diseases and increasing the burden of healthcare providers. The hospitals in Japan are widely adopting best practices such as healthcare information exchange, e-prescribing, and electronic health record systems to provide quality care to patients.
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release E-prescribing Market: The Erx Solutions Segment Accounted Largest Share | While Erx Services Segment Is Expected to Register High Growth Rate here
News-ID: 493951 • Views: …
More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…

Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for…
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow…
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…